National Health (Weighted average disclosed price - interim supplementary disclosure cycle) Determination 2012 (No. PB 58 of 2012) (Australia)

National Health (Weighted average disclosed price - interim supplementary disclosure cycle) Determination 2012 (No. PB 58 of 2012)

Subscribe to a Global-Regulation Premium Membership Today!

Key Benefits:

Unlimited Searches
Weekly Updates on New Laws
Access to 5,345,848 Global Laws from 110 Countries
View the Original Law Side-by-Side with the Translation

Subscribe Now for only USD$40 per month.

PB 58 of 2012
National Health (Weighted average disclosed price – interim supplementary disclosure cycle) Determination 2012
National Health Act 1953
I, FELICITY McNEILL, First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health and Ageing, delegate of the Minister for Health, make this determination under subsection 99ADB(4) and paragraph 99ADH(1)(aa) of the National Health Act 1953.
Dated         17 August 2012

FELICITY McNEILL

First Assistant Secretary
Pharmaceutical Benefits Division
Department of Health and Ageing

1              Name of Determination
       (1)     This Determination is the National Health (Weighted average disclosed price – interim supplementary disclosure cycle) Determination 2012.
       (2)     This Determination may also be cited as PB 58 of 2012.
2              Commencement
                This Determination commences on the day after it is registered.
3                   Definitions

In this Determination:

Act means the National Health Act 1953.

adjusted approved ex-manufacturer price has the same meaning as in subsection 99ADB(1) of the Act.

adjusted approved price to pharmacists has the same meaning as in subsection 99ADB(1) of the Act.

interim supplementary disclosure cycle has the same meaning as paragraph 37EB (2) (b), of the National Health (Pharmaceutical Benefits) Regulations 1960.

unadjusted price reduction has the same meaning as in subsection 99ADB(1) of the Act.

weighted average disclosed price has the same meaning as in subsection 99ADB(1) of the Act.

4                   Weighted average disclosed price for brands of pharmaceutical items – unadjusted price reduction is at least 10%

For subsection 99ADB(4) of the Act, the weighted average disclosed price specified in column 3 of an item in Schedule 1 is the weighted average disclosed price for the brand of pharmaceutical item specified in column 2 of the same item in Schedule 1.

5                   Weighted average disclosed price for brands of pharmaceutical items – unadjusted price reduction is less than 10%

For subsection 99ADB(4) of the Act, the weighted average disclosed price specified in column 3 of an item in Schedule 2 is the weighted average disclosed price for the brand of pharmaceutical item specified in column 2 of the same item in Schedule 2.

6                   Adjusted approved ex-manufacturer price for brands of pharmaceutical items – unadjusted price reduction is at least 10%

For paragraph 99ADB(4) of the Act, the adjusted approved ex-manufacturer price for a brand of pharmaceutical item specified in column 2 of Schedule 1 is an amount equal to the amount of the weighted average disclosed price of that brand of pharmaceutical item determined under section 4 of this instrument.

7                   Adjusted approved price to pharmacists for brands of pharmaceutical items – unadjusted price reduction is at least 10%

For paragraph 99ADB(4) of the Act, the adjusted approved price to pharmacists specified in column 4 of an item in Schedule 1 is the adjusted approved price to pharmacists for the brand of pharmaceutical item specified in column 2 of the same item in Schedule 1.

8                   Reduction Day

For paragraph 99ADH(1)(aa) of the Act, a brand of pharmaceutical item in the interim supplementary disclosure cycle with a data collection period ending at the end of 31 May 2012 has a reduction day of 1 December 2012.
Schedule 1

Brands of pharmaceutical items – unadjusted price reduction is at least 10%

Column 1
Column 2
Column 3
Column 4

Item
Brand of Pharmaceutical Item
Weighted average disclosed price
Adjusted approved price to pharmacists

Listed Drug
Form
Manner of administration
Brand

1
Docetaxel
Injection set containing 1 single use vial concentrate for I.V. infusion 20 mg (anhydrous) in 0.5 mL with solvent
Injection
Taxotere
68.61
73.77

2
Docetaxel
Injection set containing 1 single use vial concentrate for I.V. infusion 80 mg (anhydrous) in 2 mL with solvent
Injection
Taxotere
275.00
295.68

3
Docetaxel
Powder for I.V. infusion 20 mg with solvent
Injection
Docetaxel SUN
68.61
73.77

4
Docetaxel
Powder for I.V. infusion 80 mg with solvent
Injection
Docetaxel SUN
275.00
295.68

5
Docetaxel
Solution concentrate for I.V. infusion 140 mg in 7 mL
Injection
Oncotaxel 140
479.17
515.20

6
Docetaxel
Solution concentrate for I.V. infusion 160 mg in 16 mL
Injection
DBL Docetaxel Concentrated Injection
549.99
591.35

7
Docetaxel
Solution concentrate for I.V. infusion 20 mg in 1 mL
Injection
Oncotaxel 20
68.61
73.77

8
Docetaxel
Solution concentrate for I.V. infusion 20 mg in 1 mL
Injection
Taxotere
68.61
73.77

9
Docetaxel
Solution concentrate for I.V. infusion 20 mg in 2 mL
Injection
DBL Docetaxel Concentrated Injection
68.61
73.77

10
Docetaxel
Solution concentrate for I.V. infusion 20 mg in 2 mL
Injection
Docetaxel Ebewe
68.61
73.77

11
Docetaxel
Solution concentrate for I.V. infusion 20 mg in 2 mL
Injection
Docetaxel Sandoz
68.61
73.77

12
Docetaxel
Solution concentrate for I.V. infusion 80 mg in 4 mL
Injection
Oncotaxel 80
275.00
295.68

13
Docetaxel
Solution concentrate for I.V. infusion 80 mg in 4 mL
Injection
Taxotere
275.00
295.68

14
Docetaxel
Solution concentrate for I.V. infusion 80 mg in 8 mL
Injection
DBL Docetaxel Concentrated Injection
275.00
295.68

15
Docetaxel
Solution concentrate for I.V. infusion 80 mg in 8 mL
Injection
Docetaxel Ebewe
275.00
295.68

16
Docetaxel
Solution concentrate for I.V. infusion 80 mg in 8 mL
Injection
Docetaxel Sandoz
275.00
295.68

17
Pioglitazone
Tablet 15 mg (as hydrochloride)
Oral
Acpio 15
27.74
29.83

18
Pioglitazone
Tablet 15 mg (as hydrochloride)
Oral
Actos
27.74
29.83

19
Pioglitazone
Tablet 15 mg (as hydrochloride)
Oral
APOTEX-Pioglitazone
27.74
29.83

20
Pioglitazone
Tablet 15 mg (as hydrochloride)
Oral
Chem mart Pioglitazone
27.74
29.83

21
Pioglitazone
Tablet 15 mg (as hydrochloride)
Oral
Pharmacor Pioglitazone 15
27.74
29.83

22
Pioglitazone
Tablet 15 mg (as hydrochloride)
Oral
Pioglitazone generichealth 15
27.74
29.83

23
Pioglitazone
Tablet 15 mg (as hydrochloride)
Oral
Pioglitazone Sandoz
27.74
29.83

24
Pioglitazone
Tablet 15 mg (as hydrochloride)
Oral
Pioglitazone-GA
27.74
29.83

25
Pioglitazone
Tablet 15 mg (as hydrochloride)
Oral
Pizaccord
27.74
29.83

26
Pioglitazone
Tablet 15 mg (as hydrochloride)
Oral
Terry White Chemists Pioglitazone
27.74
29.83

27
Pioglitazone
Tablet 15 mg (as hydrochloride)
Oral
Vexazone
27.74
29.83

28
Pioglitazone
Tablet 30 mg (as hydrochloride)
Oral
Acpio 30
42.67
45.88

29
Pioglitazone
Tablet 30 mg (as hydrochloride)
Oral
Actos
42.67
45.88

30
Pioglitazone
Tablet 30 mg (as hydrochloride)
Oral
APOTEX-Pioglitazone
42.67
45.88

31
Pioglitazone
Tablet 30 mg (as hydrochloride)
Oral
Chem mart Pioglitazone
42.67
45.88

32
Pioglitazone
Tablet 30 mg (as hydrochloride)
Oral
Pharmacor Pioglitazone 30
42.67
45.88

33
Pioglitazone
Tablet 30 mg (as hydrochloride)
Oral
Pioglitazone generichealth 30
42.67
45.88

34
Pioglitazone
Tablet 30 mg (as hydrochloride)
Oral
Pioglitazone Sandoz
42.67
45.88

35
Pioglitazone
Tablet 30 mg (as hydrochloride)
Oral
Pioglitazone-GA
42.67
45.88

36
Pioglitazone
Tablet 30 mg (as hydrochloride)
Oral
Pizaccord
42.67
45.88

37
Pioglitazone
Tablet 30 mg (as hydrochloride)
Oral
Terry White Chemists Pioglitazone
42.67
45.88

38
Pioglitazone
Tablet 30 mg (as hydrochloride)
Oral
Vexazone
42.67
45.88

39
Pioglitazone
Tablet 45 mg (as hydrochloride)
Oral
Acpio 45
55.48
59.65

40
Pioglitazone
Tablet 45 mg (as hydrochloride)
Oral
Actos
55.48
59.65

41
Pioglitazone
Tablet 45 mg (as hydrochloride)
Oral
APOTEX-Pioglitazone
55.48
59.65

42
Pioglitazone
Tablet 45 mg (as hydrochloride)
Oral
Chem mart Pioglitazone
55.48
59.65

43
Pioglitazone
Tablet 45 mg (as hydrochloride)
Oral
Pharmacor Pioglitazone 45
55.48
59.65

44
Pioglitazone
Tablet 45 mg (as hydrochloride)
Oral
Pioglitazone generichealth 45
55.48
59.65

45
Pioglitazone
Tablet 45 mg (as hydrochloride)
Oral
Pioglitazone Sandoz
55.48
59.65

46
Pioglitazone
Tablet 45 mg (as hydrochloride)
Oral
Pioglitazone-GA
55.48
59.65

47
Pioglitazone
Tablet 45 mg (as hydrochloride)
Oral
Pizaccord
55.48
59.65

48
Pioglitazone
Tablet 45 mg (as hydrochloride)
Oral
Terry White Chemists Pioglitazone
55.48
59.65

49
Pioglitazone
Tablet 45 mg (as hydrochloride)
Oral
Vexazone
55.48
59.65

50
Risedronic Acid
Tablet (enteric coated) containing risedronate sodium 35 mg
Oral
Actonel EC
25.11
27.00

51
Risedronic Acid
Tablet containing risedronate sodium 150 mg
Oral
Actonel Once-a-Month
27.21
29.26

52
Risedronic Acid
Tablet containing risedronate sodium 30 mg
Oral
Actonel
165.89
178.36

53
Risedronic Acid
Tablet containing risedronate sodium 35 mg
Oral
Acris Once-a-Week
25.11
27.00

54
Risedronic Acid
Tablet containing risedronate sodium 35 mg
Oral
APO-Risedronate
25.11
27.00

55
Risedronic Acid
Tablet containing risedronate sodium 35 mg
Oral
Chem mart Risedronate
25.11
27.00

56
Risedronic Acid
Tablet containing risedronate sodium 35 mg
Oral
Risedro once a week
25.11
27.00

57
Risedronic Acid
Tablet containing risedronate sodium 35 mg
Oral
Risedronate Sandoz
25.11
27.00

58
Risedronic Acid
Tablet containing risedronate sodium 35 mg
Oral
Risedronate-GA
25.11
27.00

59
Risedronic Acid
Tablet containing risedronate sodium 35 mg
Oral
Terry White Chemists Risedronate
25.11
27.00

60
Risedronic Acid
Tablet containing risedronate sodium 5 mg
Oral
Actonel
25.11
27.00

Schedule 2

Brands of pharmaceutical items – unadjusted price reduction is less than 10%

Column 1
Column 2
Column 3

Item
Brand of Pharmaceutical Item
Weighted average disclosed price

Listed Drug
Form
Manner of administration
Brand

1
Perindopril with amlodipine
Tablet containing 10 mg perindopril arginine with 10 mg amlodipine (as besylate)
Oral
Coveram
27.36

2
Perindopril with amlodipine
Tablet containing 10 mg perindopril arginine with 10 mg amlodipine (as besylate)
Oral
Reaptan 10/10
27.36

3
Perindopril with amlodipine
Tablet containing 10 mg perindopril arginine with 5 mg amlodipine (as besylate)
Oral
Coveram
21.45

4
Perindopril with amlodipine
Tablet containing 10 mg perindopril arginine with 5 mg amlodipine (as besylate)
Oral
Reaptan 10/5
21.45

5
Perindopril with amlodipine
Tablet containing 5 mg perindopril arginine with 10 mg amlodipine (as besylate)
Oral
Coveram
22.67

6
Perindopril with amlodipine
Tablet containing 5 mg perindopril arginine with 10 mg amlodipine (as besylate)
Oral
Reaptan 5/10
22.67

7
Perindopril with amlodipine
Tablet containing 5 mg perindopril arginine with 5 mg amlodipine (as besylate)
Oral
Coveram
16.73

8
Perindopril with amlodipine
Tablet containing 5 mg perindopril arginine with 5 mg amlodipine (as besylate)
Oral
Reaptan 5/5
16.73

Note
1.       All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003. See http://www.frli.gov.au.